The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Activation of Placental mTOR Signaling and Amino Acid Transporters in Obese Women Giving Birth to Large Babies
Open accessAbstract
CONTEXT: Babies of obese women are often large at birth, which is associated with perinatal complications and metabolic syndrome later in life. The mechanisms linking maternal obesity to fetal overgrowth are largely unknown. OBJECTIVE: We tested the hypothesis that placental insulin/IGF-I and mammalian target of rapamycin (mTOR) signaling is activated and amino acid transporter activity is increased in large babies of obese women. DESIGN AND SETTING: Pregnant women were recruited prospectively for collection of placental tissue at a university hospital and academic biomedical center. PATIENTS OR OTHER PARTICIPANTS: Twenty-three Swedish pregnant women with first trimester body mass index ranging from 18.5 to 44.9 kg/m(2) and with uncomplicated pregnancies participated in the study. INTERVENTIONS: There were no interventions. MAIN OUTCOME MEASURES: We determined the phosphorylation of key signaling molecules (including Akt, IRS-1, S6K1, 4EBP-1, RPS6, and AMPK) in the placental insulin/IGF-I, AMPK, and mTOR signaling pathways. The activity and protein expression of the amino acid transporter systems A and L were measured in syncytiotrophoblast microvillous plasma membranes. RESULTS: Birth weights (range, 3025-4235 g) were positively correlated to maternal body mass index (P < 0.05). The activity of placental insulin/IGF-I and mTOR signaling was positively correlated (P < 0.001), whereas AMPK phosphorylation was inversely (P < 0.05) correlated to birth weight. Microvillous plasma membrane system A, but not system L, activity and protein expression of the system A isoform SNAT2 were positively correlated to birth weight (P < 0.001). CONCLUSIONS: Up-regulation of specific placental amino acid transporter isoforms may contribute to fetal overgrowth in maternal obesity. This effect may be mediated by activation of insulin/IGF-I and mTOR signaling pathways, which are positive regulators of placental amino acid transporters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, a linear relationship between placental mTOR activity and birth weight has been found across a wide range of maternal body mass index (279).”
From Placental Origins of Chronic Disease (2016) · cites this paper as [279]
In the citing paper
“Thus, activity of system A, but not system L, transporters in the apical membrane of the syncytiotrophoblast correlates positively with birth weight, and may contribute to fetal overgrowth in cases of maternal obesity (279).”
From Placental Origins of Chronic Disease (2016) · cites this paper as [279]
In the citing paper
“By contrast, increased placental mTOR signaling is associated with large for gestational age babies delivered by obese women (279).”
From Placental Origins of Chronic Disease (2016) · cites this paper as [279]
In the citing paper
“By contrast, in obese women delivering larger infants, placental GLUT1 expression and System A activity are higher in the basal and microvillous membranes, respectively, than seen in women with a lean BMI (1,279).”
From Placental Origins of Chronic Disease (2016) · cites this paper as [279]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
Sebire, N. J., Jolly, M., Harris, J. P., Wadsworth, J., Joffe, M., Beard, R. W., Regan, L., & Robinson, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801670 · Cited by 1,740
Pregnancy complications and outcomes among overweight and obese nulliparous women
Baeten, J. M., Bukusi, E. A., & Lambe, M. P. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.3.436 · Cited by 762
The influence of obesity and diabetes on the prevalence of macrosomia
Ehrenberg, H. M., Mercer, B. M., & Catalano, P. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.05.052 · Cited by 670
Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways
Ramsay, J. E., Ferrell, W. R., Crawford, L., Wallace, A. M., Greer, I. A., & Sattar, N. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020311 · Cited by 659
Yung, H.-W., Calabrese, S., Hynx, D., Hemmings, B. A., Cetin, I., Charnock-Jones, D. S., & Burton, G. J. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071193 · Cited by 388
Constância, M., Angiolini, E., Sandovici, I., Smith, P., Smith, R., Kelsey, G., Dean, W., Ferguson-Smith, A., Sibley, C. P., Reik, W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504468103 · Cited by 323
Glazier, J. D., Cetin, I., Perugino, G., Ronzoni, S., Grey, A. M., Mahendran, D., Marconi, A. M., Pardi, G., & Sibley, C. P. (1997) · Pediatric Research · doi:10.1203/00006450-199710000-00016 · Cited by 287
Roos, S., Jansson, N., Palmberg, I., Säljö, K., Powell, T. L., & Jansson, T. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129676 · Cited by 283
Self-citationEvers, I. M., de Valk, H. W., Mol, B. W., ter Braak, E. W. M. T., & Visser, G. H. A. (2002) · Diabetologia · doi:10.1007/s00125-002-0958-7 · Cited by 280
Cited by
Sorted by citations
Catalano, P. M., & Shankar, K. (2017) · BMJ · doi:10.1136/bmj.j1 · Cited by 1,306
Placental Origins of Chronic Disease
Burton, G. J., Fowden, A. L., & Thornburg, K. L. (2016) · Physiological Reviews · doi:10.1152/physrev.00029.2015 · Cited by 717
Inflammation in maternal obesity and gestational diabetes mellitus
Pantham, P., Aye, I. L. M. H., & Powell, T. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.04.006 · Cited by 599
Self-citationDevelopmental origins of metabolic diseases
Hoffman, D. J., Powell, T. L., Barrett, E. S., & Hardy, D. B. (2020) · Physiological Reviews · doi:10.1152/physrev.00002.2020 · Cited by 504
Self-citationMaternal–Fetal Nutrient Transport in Pregnancy Pathologies: The Role of the Placenta
Brett, K., Ferraro, Z. M., Yockell‐Lelièvre, J., Gruslin, A., & Adamo, K. B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916153 · Cited by 459
Metadata
- Authors
- Jansson, N., Rosario, F. J., Gaccioli, F., Lager, S., Jones, H. N., Roos, S., Jansson, T., & Powell, T. L.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Cincinnati Children's Hospital Medical Center (US)
- University of Gothenburg (SE)
- Corresponding author
- Powell, Theresa L.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-01
- Volume
- 98
- Issue
- 1
- Pages
- 105-113
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3537112
- OpenAlex
- W1973061822
- Cited by
- 305
- References
- 43
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 19 · 2023: 23 · 2022: 21 · 2021: 22 · 2020: 29 · 2019: 28 · 2018: 21 · 2017: 31 · 2016: 23 · 2015: 31 · 2014: 15 · 2013: 9
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet (14555)
- National Institutes of Health (5r01hd068370-11, HD68370)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK089989, DK89989)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD068370, HD68370)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- maternal obesity, macrosomia, placenta, mTOR signaling, amino acid transporters, system A, SNAT2, system L, AMPK, syncytiotrophoblast, birth weight, S6K1, 4E-BP1, Akt, IRS-1
- MeSH terms
- Adult, Birth Weight, Female, Fetal Macrosomia, Humans, Infant, Newborn, Insulin-Like Growth Factor I, Obesity, Placenta, Pregnancy, Pregnancy Complications, Cohort Studies, Signal Transduction, Body Mass Index, Amino Acid Transport Systems, Young Adult, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
